Loading…
Loading…
Study finds 42% of hospitals and health systems face at least $1 million in annual recoupment requests, as new research highlights growing demand for AI-powered automation LEHI, Utah and LOUISVILLE, Ky., Oct. 22, 2026 /PRNewswire/ -- Waystar (Nasdaq: WAY), a provider of leading healthcare payment software, and Modern Healthcare today announced new research showing that payer recoupments create significant financial exposure, drain staff capacity, and make it harder for healthcare organizations to protect revenue after payment.
LEHI, Utah and LOUISVILLE, Ky., Oct. 14, 2026 /PRNewswire/ -- Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, today announced it will report financial results for the third quarter ended September 30, 2026, after market close on Monday, November 2, 2026.
PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law announces that it is investigating Waystar Holding Corp. (NASDAQ: WAY) (“Waystar”) on behalf of the company's stockholders.Click here to request additional information: https://kaskelalaw.com/case/waystar-holding-corp/The investigation seeks to determine whether Waystar and/or the company's officers and directors violated the securities laws or breached their fiduciary duties in connection with recent corporate actions.Waystar stockholders are encourage.
Waystar (WAY) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Healthcare industry payments management software company Waystar is reportedly considering a potential sale. Such a deal could return Waystar to private ownership two years after the company went public, according to a Tuesday (Sept.
U.S. stocks were lower, with the Dow Jones index falling around 300 points on Tuesday.
Software provider Waystar , whose products are used by hospitals and doctors to manage payments, is exploring options including a potential sale that could return it to private hands two years after a stock market listing in New York, seven sources familiar with the matter said.
Waystar Holding earns a buy rating for its compelling mix of 18% revenue growth, 34% subscription growth, and 42.8% adjusted EBITDA margin. WAY's expanding AI capabilities and the Iodine Software acquisition enhance platform value, drive cross-selling, and increase the addressable market by over 15%. Subscription revenue and net revenue retention of 108% underscore a stable, recurring revenue base with strong client expansion and upselling.